Literature DB >> 29016850

Mice lacking cyclin-dependent kinase-like 5 manifest autistic and ADHD-like behaviors.

Cian-Ling Jhang1, Tzyy-Nan Huang2, Yi-Ping Hsueh2, Wenlin Liao1,3.   

Abstract

Neurodevelopmental disorders frequently share common clinical features and appear high rate of comorbidity, such as those present in patients with attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). While characterizing behavioral phenotypes in the mouse model of cyclin-dependent kinase-like 5 (CDKL5) disorder, a neurodevelopmental disorder caused by mutations in the X-linked gene encoding CDKL5, we found that these mice manifested behavioral phenotypes mimicking multiple key features of ASD, such as impaired social interaction and communication, as well as increased stereotypic digging behaviors. These mice also displayed hyper-locomotion, increased aggressiveness and impulsivity, plus deficits in motor and associative learning, resembling primary symptoms of ADHD. Through brain region-specific biochemical analysis, we uncovered that loss of CDKL5 disrupts dopamine synthesis and the expression of social communication-related key genes, such as forkhead-box P2 and mu-opioid receptor, in the corticostriatal circuit. Together, our findings support that CDKL5 plays a role in the comorbid features of autism and ADHD, and mice lacking CDKL5 may serve as an animal model to study the molecular and circuit mechanisms underlying autism-ADHD comorbidity.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29016850     DOI: 10.1093/hmg/ddx279

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

1.  Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder.

Authors:  Tatiana Varela; Débora Varela; Gil Martins; Natércia Conceição; M Leonor Cancela
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

2.  Neuron-Type Specific Loss of CDKL5 Leads to Alterations in mTOR Signaling and Synaptic Markers.

Authors:  Ethan Schroeder; Li Yuan; Eunju Seong; Cheryl Ligon; Nicholas DeKorver; C B Gurumurthy; Jyothi Arikkath
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

3.  Genetic disruption of Grm5 causes complex alterations in motor activity, anxiety and social behaviors.

Authors:  Jian Xu; John J Marshall; Stephen Kraniotis; Toshihiro Nomura; Yongling Zhu; Anis Contractor
Journal:  Behav Brain Res       Date:  2021-05-21       Impact factor: 3.352

4.  Abnormal behaviours relevant to neurodevelopmental disorders in Kirrel3-knockout mice.

Authors:  Tomoko Hisaoka; Tadasuke Komori; Toshio Kitamura; Yoshihiro Morikawa
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

5.  Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory.

Authors:  Kosuke Okuda; Keizo Takao; Aya Watanabe; Tsuyoshi Miyakawa; Masashi Mizuguchi; Teruyuki Tanaka
Journal:  PLoS One       Date:  2018-04-27       Impact factor: 3.240

6.  Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.

Authors:  Claudia Fuchs; Laura Gennaccaro; Stefania Trazzi; Stefano Bastianini; Simone Bettini; Viviana Lo Martire; Elisa Ren; Giorgio Medici; Giovanna Zoccoli; Roberto Rimondini; Elisabetta Ciani
Journal:  Neural Plast       Date:  2018-05-27       Impact factor: 3.599

Review 7.  Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.

Authors:  Syouichi Katayama; Noriyuki Sueyoshi; Tetsuya Inazu; Isamu Kameshita
Journal:  Neural Plast       Date:  2020-06-05       Impact factor: 3.599

8.  Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder.

Authors:  Leonardo Lupori; Giulia Sagona; Claudia Fuchs; Raffaele Mazziotti; Antonia Stefanov; Elena Putignano; Debora Napoli; Enrica Strettoi; Elisabetta Ciani; Tommaso Pizzorusso
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

9.  The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.

Authors:  L Trovò; C Fuchs; R De Rosa; I Barbiero; M Tramarin; E Ciani; L Rusconi; C Kilstrup-Nielsen
Journal:  Neurobiol Dis       Date:  2020-02-04       Impact factor: 5.996

10.  CDKL5 promotes proliferation, migration, and chemotherapeutic drug resistance of glioma cells via activation of the PI3K/AKT signaling pathway.

Authors:  Zhenfu Jiang; Tongtong Gong; Hong Wei
Journal:  FEBS Open Bio       Date:  2020-01-21       Impact factor: 2.792

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.